| Initial public offering of up to 14,233,964 equity shares of face value of Rs. 10 each ("Equity Shares") of Agilus Diagnostics Limited ("Company") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share)("Offer Price") aggregating up to Rs. [*] crores (the "Offer"). The offer comprises of an offer for sale of up to 14,233,964 equity shares ("Offered Shares") aggregating up to Rs. [*] crores comprising up to 2,985,075 equity shares by international finance corporation aggregating up to Rs. [*] crores, up to 7,462,700 equity shares by Nylim Jacob Ballas India Fund iii llc aggregating up to Rs. [*] crores and up to 3,786,189 equity shares by Resurgence PE Investments Limited aggregating up to Rs. [*] crores (together, the "Selling Shareholders", and such offer for sale of equity shares by the selling shareholders, the "Offer for Sale"). The offer shall constitute at least [*]% of the post-offer paid-up equity share capital of the company.
The face value of the equity share is Rs. 10 each. The offer price is [*] times the face value of the equity shares. The price band and the minimum bid lot the face value of the equity share is Rs. 10 each. The offer price is [*] times the face value of the equity shares. The price band and the minimum bid lot will be decided by the company.
|
